Amedisys, Inc.
AMED
$94.50
$0.230.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -220.52% | -47.65% | 124.31% | -25.47% | -25.57% |
| Total Depreciation and Amortization | -0.29% | 3.78% | 1.28% | 3.11% | -1.78% |
| Total Amortization of Deferred Charges | 0.00% | 0.40% | -0.40% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 702.08% | -46.71% | 16.35% | -28.40% | -4.32% |
| Change in Net Operating Assets | -61.74% | 1,098.03% | 85.39% | -463.68% | 119.37% |
| Cash from Operations | -33.46% | 101.94% | 899.65% | -110.85% | 712.73% |
| Capital Expenditure | 19.86% | 0.00% | 48.13% | -41.12% | -92.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 83.96% | -469.89% | 53.27% | -117.49% | -185.94% |
| Cash from Investing | 47.65% | -55.63% | 48.79% | -50.47% | -94.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.98% | 0.99% | -5.59% | -0.46% | -45.42% |
| Issuance of Common Stock | 151.14% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -103.41% | 81.97% | -479.90% | 70.84% | -128.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.60% | -388.41% | -205.26% | 141.84% | -2,837.80% |
| Cash from Financing | 25.73% | -7.15% | -64.68% | 36.31% | -114.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.40% | 140.33% | 301.85% | -140.49% | 361.57% |